POLYCYTHEMIA VERA (PV)
Clinical trials for POLYCYTHEMIA VERA (PV) explained in plain language.
Never miss a new study
Get alerted when new POLYCYTHEMIA VERA (PV) trials appear
Sign up with your email to follow new studies for POLYCYTHEMIA VERA (PV), keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
New combo therapy tested for rare blood disorder
Disease control Not yet recruitingThis study is testing whether a new drug called gecacitinib, when combined with an existing medication (pegylated interferon), can help control polycythemia vera. Researchers want to see if this combination can bring blood counts back to normal levels and reduce symptoms like fat…
Matched conditions: POLYCYTHEMIA VERA (PV)
Phase: NA • Sponsor: Duan Minghui • Aim: Disease control
Last updated Mar 30, 2026 14:31 UTC
-
Scientists probe why blood disorder patients struggle to exercise
Knowledge-focused Not yet recruitingThis study aims to understand why people with polycythemia vera (a rare blood disorder) often have trouble with physical activity. Researchers will test 54 patients during exercise to see if their blood becomes too thick, which might limit oxygen delivery to muscles. The goal is …
Matched conditions: POLYCYTHEMIA VERA (PV)
Phase: NA • Sponsor: Hospices Civils de Lyon • Aim: Knowledge-focused
Last updated Mar 20, 2026 14:48 UTC